story of the week
Semaglutide vs Dulaglutide Once Weekly in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Semaglutide Versus Dulaglutide Once Weekly in Patients With Type 2 Diabetes (SUSTAIN 7): A Randomised, Open-label, Phase 3b Trial
Lancet Diabetes Endocrinol 2018 Jan 31;[EPub Ahead of Print], RE Pratley, VR Aroda, I Lingvay, J Lüdemann, C Andreassen, A Navarria, A ViljoenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.